Does Obesity Influence the Outcomes of Supine Mini-Percutaneous Nephrolithotomy? A Retrospective Observational Study

Background and Objectives: The objective of this study is to evaluate the impact of obesity on postoperative outcomes following supine mini-percutaneous nephrolithotomy (mini-PCNL). Materials and Methods: This retrospective observational study included 110 consecutive patients who underwent supine mini-PCNL between October 2024 and March 2026. Patients were stratified into non-obese (BMI < 30 kg/m2, n = 59) and obese (BMI ≥ 30 kg/m2, n = 51) groups. Preoperative characteristics, stone-related parameters, and perioperative outcomes were compared. The primary endpoint was the 30-day postoperative complication rate according to the modified Clavien–Dindo classification. Secondary outcomes included operative time, hemoglobin drop, stone-free rate (SFR), and postoperative day 1 discharge rate. Results: Obese patients presented with greater cumulative stone diameter and skin-to-stone distance. Operative time was longer in the obese group (45 [40–60] min vs. 35 [30–60] min; p = 0.029). However, after adjustment for cumulative stone diameter and age, obesity was not independently associated with operative time, whereas stone size remained a significant predictor. No significant differences were observed between groups regarding hemoglobin drop (obese cohort: 9.27 ± 8.22 g/L vs. non-obese cohort: 8.88 ± 7.35 g/L; p = 0.95), SFR (obese cohort: 94.1% vs. non-obese cohort: 89.8%; p = 0.41), postoperative day 1 discharge (obese cohort: 86.3% vs. non-obese cohort: 89.8%; p = 0.768), or overall complication rates (obese cohort: 5.88% vs. non-obese cohort: 6.78%; absolute risk difference, −0.9 percentage points; 95% CI, −10.0 to 8.2; p = 1.000). Conclusions: In this cohort, no statistically significant differences were observed between obese and non-obese patients in the assessed perioperative outcomes, except for operative time, which was longer in obese patients, and the observed difference appeared to be largely explained by differences in stone burden in the present cohort. These findings support the feasibility of standardized supine mini-PCNL in obese patients, although larger prospective studies are needed to confirm these results.

Authors

Institutions

Publication Details

Journal
Medicina
Published
2026-10-09
DOI
https://doi.org/10.3390/medicina62101950
Primary Topic
Kidney Stones and Urolithiasis Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Does Obesity Influence the Outcomes of Supine Mini-Percutaneous Nephrolithotomy? A Retrospective Observational Study

Zoltán Kiss, Attila Csaba Nagy, Ioannis Kartalas Goumas, Mihály Murányi et al.
Medicina
Kidney Stones and Urolithiasis Treatments
article

Does Obesity Influence the Outcomes of Supine Mini-Percutaneous Nephrolithotomy? A Retrospective Observational Study

Zoltán Kiss, Attila Csaba Nagy, Ioannis Kartalas Goumas, Mihály Murányi, Tibor Flaskó
article en

Abstract

Background and Objectives: The objective of this study is to evaluate the impact of obesity on postoperative outcomes following supine mini-percutaneous nephrolithotomy (mini-PCNL). Materials and Methods: This retrospective observational study included 110 consecutive patients who underwent supine mini-PCNL between October 2024 and March 2026. Patients were stratified into non-obese (BMI < 30 kg/m2, n = 59) and obese (BMI ≥ 30 kg/m2, n = 51) groups. Preoperative characteristics, stone-related parameters, and perioperative outcomes were compared. The primary endpoint was the 30-day postoperative complication rate according to the modified Clavien–Dindo classification. Secondary outcomes included operative time, hemoglobin drop, stone-free rate (SFR), and postoperative day 1 discharge rate. Results: Obese patients presented with greater cumulative stone diameter and skin-to-stone distance. Operative time was longer in the obese group (45 [40–60] min vs. 35 [30–60] min; p = 0.029). However, after adjustment for cumulative stone diameter and age, obesity was not independently associated with operative time, whereas stone size remained a significant predictor. No significant differences were observed between groups regarding hemoglobin drop (obese cohort: 9.27 ± 8.22 g/L vs. non-obese cohort: 8.88 ± 7.35 g/L; p = 0.95), SFR (obese cohort: 94.1% vs. non-obese cohort: 89.8%; p = 0.41), postoperative day 1 discharge (obese cohort: 86.3% vs. non-obese cohort: 89.8%; p = 0.768), or overall complication rates (obese cohort: 5.88% vs. non-obese cohort: 6.78%; absolute risk difference, −0.9 percentage points; 95% CI, −10.0 to 8.2; p = 1.000). Conclusions: In this cohort, no statistically significant differences were observed between obese and non-obese patients in the assessed perioperative outcomes, except for operative time, which was longer in obese patients, and the observed difference appeared to be largely explained by differences in stone burden in the present cohort. These findings support the feasibility of standardized supine mini-PCNL in obese patients, although larger prospective studies are needed to confirm these results.

MedicinaVol. 62(10)
University of Debrecen (HU)
Openalex Percentile: Top 12%
Kidney Stones and Urolithiasis Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.